HPWM
NVO

Highland Private Wealth Management’s Novo Nordisk NVO Stock Holding History

Highland Private Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,470
Closed -$249K – 193
2022
Q2 		$249K Buy
+4,470
New +$248K 0.04% 150

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Highland Private Wealth Management's NVO Position: Q3 2022 in Review

Highland Private Wealth Management sold out of Novo Nordisk (NVO) in Q3 2022, closing a stake of 4,470 shares — an estimated $249K sold.

Highland Private Wealth Management first reported a position in NVO in Q2 2022 and held it in 1 quarter. The position peaked at $249K in Q2 2022. 907 funds tracked by Wall St. Rank hold NVO as of Q3 2022.

  • Highland Private Wealth Management reported no remaining Novo Nordisk position as of Q3 2022 after selling out during the quarter.
  • Highland Private Wealth Management sold 4,470 Novo Nordisk shares in Q3 2022, an estimated $249K.
  • Highland Private Wealth Management first reported a position in Novo Nordisk in Q2 2022 and held it in 1 quarter.
  • Highland Private Wealth Management's Novo Nordisk position peaked at $249K in Q2 2022.
  • 907 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2022.

Based on Highland Private Wealth Management's 13F filing for Q3 2022, filed 17 Oct 2022.